The current practice of transarterial chemoembolization for the treatment of hepatocellular carcinoma

Korean Journal of Radiology

Volumn 10, Issue 5, 2009, Pages 425-434

  Sung, Wook Shin ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Carcinoma, hepatocellular; Chemoembolization, therapeutic; Doxorubicin; Gelatin sponge, absorbable; Iodized oil

Indexed keywords

ACLARUBICIN; ALPHA FETOPROTEIN; AMINOTRANSFERASE; BILIRUBIN; CISPLATIN; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; GELATIN SPONGE; IODINATED POPPYSEED OIL; MICROSPHERE; MITOMYCIN; POLYVINYL ALCOHOL; STEEL; TAMOXIFEN; ZINOSTATIN MALEIC ACID STYRENE COPOLYMER;

ABDOMINAL PAIN; AMINOTRANSFERASE BLOOD LEVEL; ARTERY OCCLUSION; BILE DUCT OBSTRUCTION; BILIARY TRACT SURGERY; BILIRUBIN BLOOD LEVEL; BLOOD AUTOTRANSFUSION; CHEMOEMBOLIZATION; CHOLECYSTITIS; CLINICAL EVALUATION; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG RELEASE; DRUG STABILITY; DRUG TUMOR LEVEL; EMULSION; FEVER; GASTRITIS; HEPATIC ARTERY; HUMAN; LABORATORY TEST; LIVER ABSCESS; LIVER CELL CARCINOMA; LIVER CIRCULATION; LIVER FAILURE; LIVER FUNCTION; LIVER INJURY; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PALLIATIVE THERAPY; PORTAL VEIN OBSTRUCTION; PROTHROMBIN TIME; RADIOFREQUENCY ABLATION; REVIEW; RISK FACTOR; SURVIVAL RATE; SUSPENSION; TRANSARTERIAL CHEMOEMBOLIZATION; TREATMENT RESPONSE; TUMOR GROWTH; TUMOR NECROSIS; TUMOR RECURRENCE; TUMOR VASCULARIZATION; TUMOR VOLUME;

ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; GELATIN SPONGE, ABSORBABLE; HUMANS; INFUSIONS, INTRA-ARTERIAL; IODIZED OIL; LIVER NEOPLASMS;

EID: 70349171689     PISSN: 12296929     EISSN: None     Source Type: Journal    
DOI: 10.3348/kjr.2009.10.5.425     Document Type: Review

References (58)

1. Breedis C, Young G. The blood supply of neoplasms in the liver. Am J Pathol 1954;30:969-977
2. Nakashima T, Kojiro M. Pathologic characteristics of hepatocellular carcinoma. Semin Liver Dis 1986;6:259-266
3. Lee JM, Kim IH, Kwak HS, Youk JH, Han YM, Kim CS. Detection of small hypervascular hepatocellular carcinomas in cirrhotic patients: comparison of superparamagnetic iron oxideenhanced MR imaging with dual-phase spiral CT. Korean J Radiol 2003;4:1-8
4. Marelli L, Stigliano R, Triantos C, Senzolo M, Cholongitas E, Davies N, et al. Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies. Cardiovasc Intervent Radiol 2007;30:6-25 (Pubitemid 44900485)
5. Bruix J, Sherman M; Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology 2005;42:1208-1236
6. Chung JW, Kim HC, Yoon JH, Lee HS, Jae HJ, Lee W, et al. Transcatheter arterial chemoembolization of hepatocellular carcinoma: prevalence and causative factors of extrahepatic collateral arteries in 479 patients. Korean J Radiol 2006;7:257-266 (Pubitemid 44905084)
7. Chung JW, Park JH, Han JK, Choi BI, Kim TK, Han MC. Transcatheter oily chemoembolization of the inferior phrenic artery in hepatocellular carcinoma: the safety and potential therapeutic role. J Vasc Interv Radiol 1998;9:495-500
8. Ji SK, Cho YK, Ahn YS, Kim MY, Park YO, Kim JK, et al. Multivariate analysis of the predictors of survival for patients with hepatocellular carcinoma undergoing transarterial chemoembolization: focusing on superselective chemoembolization. Korean J Radiol 2008;9:534-540
9. Matsui O, Kadoya M, Yoshikawa J, Gabata T, Takashima T, Demachi H. Subsegmental transcatheter arterial embolization for small hepatocellular carcinomas: local therapeutic effect and 5-year survival rate. Cancer Chemother Pharmacol 1994;33:S84-S88 (Pubitemid 24147972)
10. Miyayama S, Matsui O, Yamashiro M, Ryu Y, Kaito K, Ozaki K, et al. Ultraselective transcatheter arterial chemoembolization with a 2-f tip microcatheter for small hepatocellular carcinomas: relationship between local tumor recurrence and visualization of the portal vein with iodized oil. J Vasc Interv Radiol 2007;18:365-376 (Pubitemid 46616707)
11. Park SH, Cho YK, Ahn YS, Park YO, Kim JK, Chung JW. Local recurrence of hepatocellular carcinoma after segmental transarterial chemoembolization: risk estimates based on multiple prognostic factors. Korean J Radiol 2007;8:111-119
12. Doppman JL, Dunnick NR, Girton M, Fauci AS, Popovsky MA. Bile duct cysts secondary to liver infarcts: report of a case and experimental production by small vessel hepatic artery occlusion. Radiology 1979;130:1-5 (Pubitemid 9087316)
13. Makuuchi M, Sukigara M, Mori T, Kobayashi J, Yamazaki S, Hasegawa H, et al. Bile duct necrosis: complication of transcatheter hepatic arterial embolization. Radiology 1985;156:331-334 (Pubitemid 15029758)
14. Nakamura H, Tanaka T, Hori S, Yoshioka H, Kuroda C, Okamura J, et al. Transcatheter embolization of hepatocellular carcinoma: assessment of efficacy in cases of resection following embolization. Radiology 1983;147:401-405 (Pubitemid 13133211)
15. Coldwell DM, Stokes KR, Yakes WF. Embolotherapy: agents, clinical applications, and techniques. Radiographics 1994;14:623-643
16. Chung JW. Transcatheter arterial chemoembolization of hepatocellular carcinoma. Hepatogastroenterology 1998;45:S1236-S1241
17. Kan Z, Sato M, Ivancev K, Uchida B, Hedgpeth P, Lunderquist A, et al. Distribution and effect of iodized poppyseed oil in the liver after hepatic artery embolization: experimental study in several animal species. Radiology 1993;186:861-866 (Pubitemid 23073535)
18. Varela M, Real MI, Burrel M, Forner A, Sala M, Brunet M, et al. Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics. J Hepatol 2007;46:474-481 (Pubitemid 46201723)
19. Doyon D, Mouzon A, Jourde AM, Regensberg C, Frileux C. Hepatic, arterial embolization in patients with malignant liver tumours (author's transl). Ann Radiol (Paris) 1974;17:593-603
20. Nakakuma K, Tashiro S, Hiraoka T, Uemura K, Konno T, Miyauchi Y, et al. Studies on anticancer treatment with an oily anticancer drug injected into the ligated feeding hepatic artery for liver cancer. Cancer 1983;52:2193-2200 (Pubitemid 14205933)
21. Kan Z, McCuskey PA, Wright KC, Wallace S. Role of Kupffer cells in iodized oil embolization. Invest Radiol 1994;29:990-993
22. Ohishi H, Uchida H, Yoshimura H, Ohue S, Ueda J, Katsuragi M, et al. Hepatocellular carcinoma detected by iodized oil. Use of anticancer agents. Radiology 1985;154:25-29
23. Okayasu I, Hatakeyama S, Yoshida T, Yoshimatsu S, Tsuruta K, Miyamoto H, et al. Selective and persistent deposition and gradual drainage of iodized oil, Lipiodol in the hepatocellular carcinoma after injection into the feeding hepatic artery. Am J Clin Pathol 1988;90:536-544 (Pubitemid 18253655)
24. Nakamura H, Hashimoto T, Oi H, Sawada S. Transcatheter oily chemoembolization of hepatocellular carcinoma. Radiology 1989;170:783-786 (Pubitemid 19062602)
25. Johnson PJ, Kalayci C, Dobbs N, Raby N, Metivier EM, Summers L, et al. Pharmacokinetics and toxicity of intraarterial adriamycin for hepatocellular carcinoma: effect of coadministration of Lipiodol. J Hepatol 1991;13:120-127
26. Heresbach D, Raoul JL, Bentue-Ferrer D, Bretagne JF, Van den Driessche J, Gastard J. Chemotherapy combined with Lipiodol. In vitro study of the kinetics of release of adriamycin. Gastroenterol Clin Biol 1989;13:775-778 (Pubitemid 19277788)
27. Sakaguchi H, Uchida H, Nishimura Y, Guo QY, Yoshimura H, Ohishi H. Pharmacokinetic study of adriamycin in the emulsion mixed with Lipiodol-difference resulting from composition and methods of preparation, and behavior after mesenteric arterial injection in rat. Gan To Kagaku Ryoho 1991;18:1349-1355
28. de Baere T, Zhang X, Aubert B, Harry G, Lagrange C, Ropers J, et al. Quantification of tumor uptake of iodized oils and emulsions of iodized oils: experimental study. Radiology 1996;201:731-735 (Pubitemid 26392622)
29. Raoul JL, Heresbach D, Bretagne JF, Ferrer DB, Duvauferrier R, Bourguet P, et al. Chemoembolization of hepatocellular carcinomas. A study of the biodistribution and pharmacokinetics of doxorubicin. Cancer 1992;70:585-590
30. Nakamura H, Hashimoto T, Oi H, Sawada S. Iodized oil in the portal vein after arterial embolization. Radiology 1988;167:415-417 (Pubitemid 18109118)
31. Takayasu K, Shima Y, Muramatsu Y, Moriyama N, Yamada T, Makuuchi M, et al. Hepatocellular carcinoma: treatment with intraarterial iodized oil with and without chemotherapeutic agents. Radiology 1987;163:345-351 (Pubitemid 17068905)
32. Kuroda C, Sakurai M, Monden M, Marukawa T, Hosoki T, Tokunaga K, et al. Limitation of transcatheter arterial chemoembolization using iodized oil for small hepatocellular carcinoma. A study in resected cases. Cancer 1991;67:81-86
33. Sasaki Y, Imaoka S, Kasugai H, Fujita M, Kawamoto S, Ishiguro S, et al. A new approach to chemoembolization therapy for hepatoma using ethiodized oil, cisplatin, and gelatin sponge. Cancer 1987;60:1194-1203 (Pubitemid 17152894)
34. Bruix J, Sala M, Llovet JM. Chemoembolization for hepatocellular carcinoma. Gastroenterology 2004;127:S179-S188
35. Kasugai H, Kojima J, Tatsuta M, Okuda S, Sasaki Y, Imaoka S, et al. Treatment of hepatocellular carcinoma by transcatheter arterial embolization combined with intraarterial infusion of a mixture of cisplatin and ethiodized oil. Gastroenterology 1989;97:965-971 (Pubitemid 19239037)
36. Kawai S, Tani M, Okamura J, Ogawa M, Ohashi Y, Monden M, et al. Prospective and randomized trial of Lipiodol-transcatheter arterial chemoembolization for treatment of hepatocellular carcinoma: a comparison of epirubicin and doxorubicin (second cooperative study). The Cooperative Study Group for Liver Cancer Treatment of Japan. Semin Oncol 1997;24:S6-38-S6-45 (Pubitemid 27209105)
37. Watanabe S, Nishioka M, Ohta Y, Ogawa N, Ito S, Yamamoto Y. Prospective and randomized controlled study of chemoembolization therapy in patients with advanced hepatocellular carcinoma. Cooperative Study Group for Liver Cancer Treatment in Shikoku area. Cancer Chemother Pharmacol 1994;33:S93-S96
38. Bartolozzi C, Lencioni R, Caramella D, Falaschi F, Cioni R, DiCoscio G. Hepatocellular carcinoma: CT and MR features after transcatheter arterial embolization and percutaneous ethanol injection. Radiology 1994;191:123-128 (Pubitemid 24098216)
39. Bruix J, Llovet JM, Castells A, Montana X, Bru C, Ayuso MC, et al. Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution. Hepatology 1998;27:1578-1583 (Pubitemid 28264682)
40. A comparison of Lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. Groupe d'Etude et de Traitement du Carcinome Hepatocellulaire. N Engl J Med 1995;332:1256-1261
41. Llovet JM, Real MI, Montana X, Planas R, Coll S, Aponte J, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 2002;359:1734-1739 (Pubitemid 34607087)
42. Lin DY, Liaw YF, Lee TY, Lai CM. Hepatic arterial embolization in patients with unresectable hepatocellular carcinoma-a randomized controlled trial. Gastroenterology 1988;94:453-456
43. Pelletier G, Roche A, Ink O, Anciaux ML, Derhy S, Rouqier P, et al. A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma. J Hepatol 1990;11:181-184
44. Pelletier G, Ducreux M, Gay F, Luboinski M, Hagege H, Dao T, et al. Treatment of unresectable hepatocellular carcinoma with Lipiodol chemoembolization: a multicenter randomized trial. Groupe CHC. J Hepatol 1998;29:129-134 (Pubitemid 28307992)
45. Lo CM, Ngan H, Tso WK, Liu CL, Lam CM, Poon RT, et al. Randomized controlled trial of transarterial Lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 2002;35:1164-1171 (Pubitemid 34454013)
46. Camma C, Schepis F, Orlando A, Albanese M, Shahied L, Trevisani F, et al. Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials. Radiology 2002;224:47-54 (Pubitemid 34680374)
47. Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 2003;37:429-442 (Pubitemid 36152543)
48. Lee HS, Kim KM, Yoon JH, Lee TR, Suh KS, Lee KU, et al. Therapeutic efficacy of transcatheter arterial chemoembolization as compared with hepatic resection in hepatocellular carcinoma patients with compensated liver function in a hepatitis B virus-endemic area: a prospective cohort study. J Clin Oncol 2002;20:4459-4465
49. Chung JW, Park JH, Han JK, Choi BI, Han MC, Lee HS, et al. Hepatic tumors: predisposing factors for complications of transcatheter oily chemoembolization. Radiology 1996;198:33-40 (Pubitemid 26008235)
50. Wigmore SJ, Redhead DN, Thomson BN, Currie EJ, Parks RW, Madhavan KK, et al. Postchemoembolisation syndrome- tumour necrosis or hepatocyte injury? Br J Cancer 2003;89:1423-1427
51. Castells A, Bruix J, Ayuso C, Bru C, Montanya X, Boix L, et al. Transarterial embolization for hepatocellular carcinoma. Antibiotic prophylaxis and clinical meaning of postembolization fever. J Hepatol 1995;22:410-415
52. Chan AO, Yuen MF, Hui CK, Tso WK, Lai CL. A prospective study regarding the complications of transcatheter intraarterial Lipiodol chemoembolization in patients with hepatocellular carcinoma. Cancer 2002;94:1747-1752 (Pubitemid 34241113)
53. Takayasu K, Moriyama N, Muramatsu Y, Shima Y, Ushio K, Yamada T, et al. Gallbladder infarction after hepatic artery embolization. AJR Am J Roentgenol 1985;144:135-138 (Pubitemid 15153894)
54. Miyayama S, Matsui O, Nishida H, Yamamori S, Minami T, Shinmura R, et al. Transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma fed by the cystic artery. J Vasc Interv Radiol 2003;14:1155-1161 (Pubitemid 37193729)
55. Song SY, Chung JW, Han JK, Lim HG, Koh YH, Park JH, et al. Liver abscess after transcatheter oily chemoembolization for hepatic tumors: incidence, predisposing factors, and clinical outcome. J Vasc Interv Radiol 2001;12:313-320
56. Kim HK, Chung YH, Song BC, Yang SH, Yoon HK, Yu E, et al. Ischemic bile duct injury as a serious complication after transarterial chemoembolization in patients with hepatocellular carcinoma. J Clin Gastroenterol 2001;32:423-427 (Pubitemid 32378276)
57. Wang MQ, Shao RH, Ye HY, Wang ZQ, Wang ZP, Liu FY. Investigation of bile duct injury after transcatheter arterial chemoembolization. Zhonghua Zhong Liu Za Zhi 2005;27:609-612
58. Cheng BQ, Jia CQ, Liu CT, Fan W, Wang QL, Zhang ZL, et al. Chemoembolization combined with radiofrequency ablation for patients with hepatocellular carcinoma larger than 3 cm: a randomized controlled trial. JAMA 2008;299:1669-1677